Dermatology

Hematologic Malignancies

Questions discussed in this category

What treatment approach is best for management of neutrophilic dermatosis in a patient with acute myeloid leukemia? Any suggestions for long term management?

1 Answer available

How do you approach balancing the potential risk of worsening actinic damage and maintaining CTCL clearance in patients treated with nb-UVB?

2 Answers available

What first-line therapies do you recommend for patients with folliculotropic mycosis fungoides?

Has topical dapsone worked?

3 Answers available

What is the role of radiotherapy in cutaneous pseudolymphoma?

Are there particular indications you use for RT? i.e. multiply recurrent, refractory to other therapies, near critical structures, unresectable (or re...

1 Answer available

Do you hold histone deacetylase (HDAC) inhibitors for patients receiving palliative radiation therapy for cutaneous lymphomas?

If so, how long before/after radiation?

1 Answer available

How do you differentiate atopic dermatitis from mycosis fungoides histologically?

1 Answer available

How long do you give systemic therapies or skin directed therapies to work before changing treatments in patients with diffuse skin limited mycoses fungoides?

Do you have a preferred sequence of therapies for diffuse skin limited MF?

1 Answer available

How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?

2 Answers available

Papers discussed in this category

JAMA network open, 2018-11-02

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

Dermatology

Hematologic Malignancies

Questions discussed in this category

Papers discussed in this category

Related Topics in Dermatology